Study Shows Tarcocimab May Improve Diabetic Retinopathy Study Shows Tarcocimab May Improve Diabetic Retinopathy

A phase 3 trial showed that tarcocimab, a biopolymer with a vascular growth factor antibody, improved vision and anatomical markers in patients with early stage diabetic retinopathy.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Ophthalmology News Source Type: news